Rising production of branded follow-on biologic drugs will be important in offsetting the effects of widespread patent expirations, though a major increase in taxes and discounts to fill the Medicare...
(PRWeb December 15, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10242369.htm